STRS OHIO - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.45 and the average weighting 1.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$21
+425.0%
12,300
+200.0%
0.00%
Q4 2022$4
-100.0%
4,1000.0%0.00%
Q3 2022$9,000
-25.0%
4,1000.0%0.00%
Q2 2022$12,000
-55.6%
4,1000.0%0.00%
Q1 2022$27,000
-20.6%
4,1000.0%0.00%
Q4 2021$34,000
+13.3%
4,1000.0%0.00%
Q3 2021$30,000
-63.4%
4,100
-66.4%
0.00%
Q2 2021$82,000
-34.4%
12,2000.0%0.00%
Q1 2021$125,000
-39.6%
12,200
-58.8%
0.00%
-100.0%
Q4 2020$207,000
-47.5%
29,600
-38.8%
0.00%
-50.0%
Q3 2020$394,000
-19.6%
48,400
-31.9%
0.00%0.0%
Q2 2020$490,000
-2.2%
71,100
-32.7%
0.00%
-33.3%
Q1 2020$501,000
-15.5%
105,600
+55.3%
0.00%
+50.0%
Q4 2019$593,000
-42.4%
68,000
-78.0%
0.00%0.0%
Q3 2019$1,030,000
+119.1%
309,600
+225.6%
0.00%0.0%
Q2 2019$470,000
+8.0%
95,100
+387.7%
0.00%0.0%
Q1 2018$435,000
+23.2%
19,500
-29.6%
0.00%0.0%
Q4 2017$353,000
-45.1%
27,700
-32.9%
0.00%
-33.3%
Q3 2017$643,000
+22.9%
41,300
+10.7%
0.00%
+50.0%
Q2 2017$523,000
+1175.6%
37,300
+1863.2%
0.00%
Q1 2017$41,0001,9000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,087,961$2,012,7281.74%
Opaleye Management Inc. 2,880,000$5,328,0001.60%
TANG CAPITAL MANAGEMENT LLC 5,300,087$9,805,1611.46%
Ardent Capital Management, Inc. 923,463$1,708,4071.23%
Beryl Capital Management LLC 610,831$1,130,0370.89%
Arena Investors LP 610,639$1,129,6820.88%
Omega Fund Management, LLC 275,513$509,6990.33%
Deep Track Capital, LP 4,259,653$7,880,3580.32%
PenderFund Capital Management Ltd. 246,310$6160.19%
GABELLI & Co INVESTMENT ADVISERS, INC. 425,100$786,4350.15%
View complete list of JOUNCE THERAPEUTICS INC shareholders